Physician

Jose Alemar, MD

According to 2025 Medicare claims, Jose Alemar, MD (NPI: 1154302156) practices hematology/oncology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 33761-9998.

Alemar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 480 traditional Medicare patients, billed 235,016 HCPCS/CPT codes, and received $3,696,392 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,287 prescription claims across 234 beneficiaries totaling $3,121,713 in drug costs, led by Revlimid (Lenalidomide). DME data shows 23 claims. Open Payments data shows 158 records totaling $5,101. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,755,015 and ending at $3,696,392. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,005,468 and ending at $3,121,713. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,260 to $1,522.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,102	361,853	$3,755,015
2016	1,214	353,761	$3,790,426
2017	1,531	377,180	$4,558,662
2018	1,717	398,627	$5,448,323
2019	1,691	485,295	$5,767,547
2020	1,372	439,198	$5,198,435
2021	1,409	325,601	$4,160,939
2022	1,177	329,297	$3,813,664
2023	250	51,474	$657,548
2024	480	235,016	$3,696,392

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	335	2,374	$2,005,468
2016	329	2,404	$2,321,846
2017	329	2,292	$2,472,143
2018	317	1,906	$2,218,742
2019	298	1,781	$2,255,396
2020	299	1,766	$3,315,738
2021	321	1,792	$3,682,056
2022	337	1,866	$5,180,985
2023	184	577	$1,133,304
2024	234	1,287	$3,121,713

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	369	$42,011
2016	11	170	$7,756
2017	N/R	118	$21,748
2018	N/R	61	$4,038
2019	N/R	73	$5,938
2020	N/R	78	$12,294
2021	N/R	43	$4,265
2022	11	95	$7,618
2023	N/R	N/R	N/R
2024	N/R	23	$1,101

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	310	1,137	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	187	302	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	197	310	$13
36415	Insertion of needle into vein for collection of blood sample	364	1,711	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	358	1,899	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	53	1,389	$799,932
Brukinsa	Zanubrutinib	19	570	$291,916
Jakafi	Ruxolitinib Phosphate	19	570	$287,397
Xtandi	Enzalutamide	18	540	$231,806
Pomalyst	Pomalidomide	11	308	$187,343

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$894
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	158	$5,101	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jose Alemar, MD?

Tedicare shows public-source Medicare data for Jose Alemar, MD (NPI 1154302156), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jose Alemar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jose Alemar, MD?

Jose Alemar, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Jose Alemar, MD have Open Payments data?

Jose Alemar, MD has 158 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.